此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

植物提取物组合 (BSL_EP028) 对关节灵活性的评估

2026年10月5日 更新者:Biosearch S.A.

评估联合使用植物提取物 (BSL_EP028) 对关节灵活性、身体机能和活力的影响的试点研究

The aim of this trial is to study the effect of the combination of plant extracts (BSL_EP028) on joint mobility, physical performance and vitality in a group of healthy older adults who remit some joint discomfort. This is a preliminary study whose purpose is to gather information for future studies.

研究概览

详细说明

The natural aging process involves several body changes that can affect to the mobility of subjects. Among them, those that affect the joints may have the greatest impact on mobility. With age, there is a progressive loss of the cartilage that covers the joints, as well as the synovial fluid, which in turn increases the stiffness of the ligaments and tendons that allow joint mobility, which implies a reduction in muscle tone and bone strength. This joint degeneration produces pain and discomfort, which leads to stiffness and restriction of movement. Therefore, and as a consequence of this loss of mobility, subjects decrease their physical performance, which can affect their mood and vitality. All of these may lead to a loss of quality of life and to an increase of the risk of future adverse health events, such as disability, institutionalization, hospitalization and the need for home medical care.

For all these reasons, and considering the increase in the ageing population worldwide, it seems relevant to develop new strategies to improve joint mobility, physical performance and vitality that are safe for the consumer, affordable and not associated with undesirable side effects. In this regard, natural plant extracts have been widely used as a traditional remedy to reduce joint pain, reduce fatigue and improve mood and physical performance.

研究类型

介入性

注册 (实际的)

50

阶段

  • 阶段2
  • 阶段1

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Madrid
      • Villaviciosa de Odón、Madrid、西班牙、28670
        • Universidad Europea de Madrid

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

55年 至 70年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Healthy men and women that have joint discomfort (WOMAC score >20)

Exclusion Criteria:

  • Consumption of pharmacological treatments on an ongoing basis that may affect joint mobility (chondroprotectors, corticoids and/or interarticular therapy or infiltrations).
  • Having undergone surgery for osteoarthritis and/or having a diagnosis of degenerative osteoarthritis made by a rheumatologist/traumatologist
  • Consuming nutritional supplements containing antioxidant substances
  • Consumption of analgesics and/or anti-inflammatory drugs on a continuous and/or scheduled basis and will continue to do so during the study, even if they do not have pain.
  • Being unable to perform the physical tests required in the study.
  • Have an allergy to some component of the study product.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:四人间

武器和干预

参与者组/臂
干预/治疗
实验性的:Combination of Plant Extracts (BSL_EP028)

Volunteers will take twice at day for 8 weeks a capsule containing the combination of a plant extracts (BSL_EP028)

Each participant will consume 2 capsules daily, in the morning and at night without any restriction in the diet nor in their habits of life.

安慰剂比较:Placebo

Volunteers will take twice at day for 8 weeks a capsule containing maltodextrin.

Each participant will consume 2 capsules daily, in the morning and at night without any restriction in the diet nor in their habits of life.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Total Score of the WOMAC (Western Ontario and McMaster. Universities Osteoarthritis index) test
大体时间:8 weeks

It is a questionnaire consisting of 24 items divided into 3 subscales:

  • Pain (5 items)
  • Stiffness (2 items)
  • Physical Function (17 items) The higher the score, the higher the amount of pain, stiffness, and a high level of functional limitations
8 weeks

次要结果测量

结果测量
措施说明
大体时间
SF-36 Vitality score
大体时间:8 weeks

Vitality score measured by the The Short Form (36) Health Survey (0-100 scale, the higher score the higher vitality)

8 weeks
Physical activity measurement
大体时间:8 weeks

Physical activity level will measure by the International Physical Activity Questionnaire (IPAQ). Results will be reported as MET minutes a week

8 weeks

其他结果措施

结果测量
措施说明
大体时间
Evaluation of Knee Pain
大体时间:8 weeks

Knee pain will evaluate by a Visual Analogue Scale (VAS), range 0 to 10, being 0 no pain and 10 the maximun pain

8 weeks
Evaluation of Hip Pain
大体时间:8 weeks

Hip pain will evaluate by a Visual Analogue Scale (VAS), range 0 to 10, being 0 no pain and 10 the maximun pain

8 weeks
Timed Up and Go test
大体时间:8 weeks

This test evaluates mobility and balance by measuring the time it takes a person to get up from a chair, walk three meters, turn around, walk to the chair, and sit.

8 weeks
30 sec Chair Stand test
大体时间:8 weeks

This test evaluates the strength and endurance of the lower limbs by measuring the number of times a person can get up from a chair, with arms crossed at the chest, for 30 seconds.

8 weeks
Manual Dynamometry
大体时间:8 weeks

Evaluates the grip strength of both hands

8 weeks
Evaluation of Muscular power and fatigue of the lower limbs
大体时间:8 weeks

We evaluate the strength-velocity profile that the person has in the lower limbs through a linear encoder. It measures the speed of execution of a squat (extension of hips and knees) with three different loads.

8 weeks
Goniometric study
大体时间:8 weeks

Evaluates the angles and ranges of movement of the hip joint (flexo-extension, abduction-adduction, internal-external rotation) and the femorotibial (flexo-extension).

8 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Helios Pareja Galeano、Universidad Europea de Madrid

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2019年10月15日

初级完成 (实际的)

2020年10月15日

研究完成 (实际的)

2020年10月15日

研究注册日期

首次提交

2019年7月22日

首先提交符合 QC 标准的

2019年7月22日

首次发布 (实际的)

2019年7月23日

研究记录更新

最后更新发布 (实际的)

2026年10月6日

上次提交的符合 QC 标准的更新

2026年10月5日

最后验证

2019年7月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • C028

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅